desethylprocainamide: metabolite of procainamide; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 156868 |
SCHEMBL ID | 3783267 |
MeSH ID | M0091656 |
Synonym |
---|
deethylprocainamide |
SCHEMBL3783267 |
4-amino-n-[2-(ethylamino)ethyl]benzamide |
pade |
desethylprocainamide |
benzamide, 4-amino-n-(2-(ethylamino)ethyl)- |
76806-95-6 |
DTXSID50227624 |
A901921 |
4-amino-n-(2-(ethylamino)ethyl)benzamide |
Excerpt | Reference | Relevance |
---|---|---|
" Acecainide renal clearance, nonrenal clearance, steady-state volume of distribution, and other pharmacokinetic parameters were estimated using standard approaches." | ( Acecainide pharmacokinetics in normal subjects of known acetylator phenotype. Boudoulas, H; Coyle, JD; Lima, JJ, 1991) | 0.28 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |